In this video, Daniela Beyer-Bontognali, RN, University Hospital of Zurich, Zurich, Switzerland, discusses her presentation at the EBMT-EHA 4th European CAR T-cell Meeting, detailing the topics of her presentation. Ms Beyer-Bontognali mentions that there will be a focus on early neurologic symptoms in the context of immune effector cell-associated neurotoxicity syndrome (ICANS), with a comparison of three case studies. Ms Beyer-Bontognali also highlights the importance of having standardized assessment and screening tools for early detection and will further discuss how patients are treated at the University Hospital of Zurich. This interview took place at the EBMT-EHA 4th European CAR T-cell Meeting which was held virtually in 2022.